“Comparative Effectiveness and Safety of High-Intensity Statins (Atorvastatin Vs Rosuvastatin) in Coronary Heart Disease Patients After Percutaneous Coronary Intervention (PCI) : A Literature Review”. 2026. Journal of Pharmaceutical and Sciences 9 (3): 2815-26. https://doi.org/10.36490/journal-jps.com.v9i3.1676.